New pill targets advanced cancers in early human trial
Disease control
Ongoing
This early-stage study is testing a new oral medication called IMM-1-104 in people with advanced solid tumors that have spread. The main goals are to find a safe dose and see if the drug can shrink tumors in cancers like pancreatic, melanoma, and lung cancer. The drug is being te…
Phase: PHASE1, PHASE2 • Sponsor: Immuneering Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC